Scientists search for clues in cancer samples to predict drug success

NCT ID NCT04257162

Summary

This study aims to understand why some patients respond better than others to the cancer drug trastuzumab deruxtecan. Researchers will analyze tumor and blood samples from 180 patients with metastatic cancer who have received this treatment. The goal is to find biological markers that can predict which patients will benefit most from the drug.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • H.Univ. Arnau de Vilanova de Lleida

    Lleida, Lleida, Spain

  • Hospital Clínic de Barcelona

    Barcelona, Barcelona, 08036, Spain

  • Hospital La Paz

    Madrid, Madrid, 28046, Spain

  • Hospital Universitari Vall d' Hebron

    Barcelona, Spain

  • Hospital Universitario 12 de octubre

    Madrid, Spain

  • Hospital Universitario Virgen de la Arrixaca

    Murcia, 30120, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Spain

  • Hospital Universitario de Canarias

    Santa Cruz de Tenerife, Canary Islands, 38320, Spain

  • Hospital Universitario de Jerez

    Jerez de la Frontera, Cadiz, 11407, Spain

  • Hospital Virgen de Macarena

    Seville, Sevilla, Spain

  • Hospital Virgen de la Victoria

    Málaga, Spain

  • Hospital del Mar

    Barcelona, Barcelona, 08003, Spain

  • ICO Badalona

    Badalona, Barcelona, Spain

  • ICO Hospitalet

    Barcelona, Spain

  • Instituto Valenciano de Oncología (IVO)

    Valencia, Valencia, 46009, Spain

Conditions

Explore the condition pages connected to this study.